CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Role of non invasive pressure ventilation in patients with acute exacerbation of copd and to determine its outcome

Author: 
Dr. K. Ramesh Kumar, Dr. B. Phani Kumar and Dr. Bhardwaj Reddy
Subject Area: 
Health Sciences
Abstract: 

▪ The present study was conducted to understand the role of NIPPV in patients with acute exacerbation of COPD who are medically unresponsive. The sample size was 40. ▪ The mean age of the study population was 60.7± 7.2 yrs. ▪ Out of the 40 cases included in the study, 36 (90%) were males and 4 (10%) were females, sex ratio 9:1(male:female). ▪ A history of smoking was obtained in 90% of study population. ▪ The Borg dyspnoea score improved from 5 at baseline to 1.4 ± 0.07 at discharge. (p <0.0001) ▪ The mean respiratory rate dropped from 34.8 ± 4.4 before NIV to 13.82 ± 1.96 (p <0.0001) at discharge. Heart rate too decreased from 102.4 ± 10.9 to 77.1 ± 9.65(p <0.0001). ▪ The mean pH changed from 7.29± 0.02 at baseline to 7.4 ±0.03 at discharge (p <0.0001). ▪ There was also a marked improvement in mean PaCO2 and PaO2 which changed from, 67.3 ± 5.61, 54.6 ± 8.85 at baseline to 50.02 ± 4.08, 75.1 ± 9.71 at the time of discharge respectively (p<0.0001 for both parameters). ▪ Respiratory rate at baseline was significantly higher in the patients who failed to respond to NIV and there was a significant improvement in the clinical and blood gas parameters within the 1st of NIV in the successful group whereas no such improvement was observed in the failure group. ▪ In the present study NIPPV was successful in 34 patients (85%) and 6 patients (15%) failed to respond and required intubation. Of them, 2 patients did not consent and left against medical advice. 4 were intubated and all of them eventually expired. No mortality was observed in the patients improved and continued on NIPPV. ▪ The mean IPAP used in the present study was 16.5 ± 0.9 and mean EPAP used was 5.2±0.52. ▪ NIPPV was used for an average of 38.5±13 hrs. ▪ The incidence of complications in the present study was 10% which included aspiration pneumonia (2.5%), irritation of eyes (5%) and dryness of mouth (2.5%). ▪ The mean duration of hospital stay in the present study was 10.32±3.46 days. Our results strongly support and encourage the use of NIPPV as a first line ventilatory management in patients with respiratory failure due to acute exacerbations of COPD.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran